v3.8.0.1

Note 14 - Net Loss Per Share of Common Stock | 12 Months Ended
--- | ---
Dec. 31, 2017
Notes to Financial Statements |
Earnings Per Share [Text Block] | 14. Net Loss per Share of Common Stock The Company ’s basic net loss per share of common stock is calculated by dividing the net loss by the weighted average number of shares of common stock outstanding for the period. The diluted net loss per share of common stock is computed by giving effect to all potential common stock equivalents outstanding for the period determined using the treasury stock method. For purposes of this calculation, options to purchase common stock and warrants to purchase common stock were considered to be common stock equivalents. In periods with a reported net loss, common stock equivalents are excluded from the calculation of diluted net loss per share of common stock if their effect is antidilutive. The PIPE warrants expired during the year ended December 31, 2017. During the year ended December 31, 2016, the exercise price of the PIPE warrants exceeded the average of AcelRx’s closing share price in the period. As a result, the PIPE warrants were anti-dilutive during the year ended December 31, 2016. However, during the year ended December 31, 2015, the PIPE warrants had a dilutive impact to net loss per share due to a lower share price at December 31, 2015, compared to the closing share price on December 31, 2014. The decrease in share price created a lower Black-Scholes value and lower liability for the PIPE warrants, which resulted in other income during the year ended December 31, 2015. The calculation of diluted net loss per share requires that, to the extent the average market price of the underlying shares for the reporting period exceeds the exercise price of the PIPE warrants and the presumed exercise of such securities are dilutive to loss per share for the period, adjustments to net loss used in the calculation are required to remove the change in fair value of the PIPE warrants for the period. Likewise, adjustments to the denominator are required to reflect the related dilutive shares. The following table is a reconciliation of the numerators and denominators used in the calculation of basic and diluted net loss per share computations for the years ended December 31, 2017, 2016 and 2015:
|  | Years Ended December 31, |
|  | 201 7 |  |  | 201 6 |  |  | 201 5 |
|  | (in thousands, except share and per share amounts) |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net loss used to compute net loss per share |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (51,508 | ) |  | $ | (43,157 | ) |  | $ | (24,399 | )
Adjustments for change in fair value of warrant liability |  |  | — |  |  |  | — |  |  |  | (2,120 | )
Diluted |  | $ | (51,508 | ) |  | $ | (43,157 | ) |  | $ | (26,519 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Weighted average shares outstanding used to compute net loss per share: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 46,883,535 |  |  |  | 45,313,118 |  |  |  | 44,300,099 |
Dilutive effect of warrants |  |  | — |  |  |  | — |  |  |  | 168,341 |
Diluted |  |  | 46,883,535 |  |  |  | 45,313,118 |  |  |  | 44,468,440 |
Net loss per share —basic |  | $ | (1.10 | ) |  | $ | (0.95 | ) |  | $ | (0.55 | )
Net loss per share —diluted |  | $ | (1.10 | ) |  | $ | (0.95 | ) |  | $ | (0.60 | )
The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been antidilutive:
|  | Year Ended December 31, |
|  | 201 7 |  |  | 201 6 |  |  | 201 5 |
ESPP and stock options to purchase common stock |  |  | 8,767,783 |  |  |  | 6,395,879 |  |  |  | 4,699,121 |
Convertible debt into common stock |  |  | — |  |  |  | 553,763 |  |  |  | 553,763 |
Common stock warrants |  |  | 176,730 |  |  |  | 692,611 |  |  |  | 180,155 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration